The role of BMP antagonists in ovarian follicle development
The role of BMP antagonists in ovarian follicle development
批准号:
BB/H00002X/1
负责人:
Kate Hardy
金额:
$49.06万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2009
资助国家:
英国
项目状态:
已结题
起止时间:
2009 至 --
中文摘要
女性生育率随着年龄的增长而下降,这对计划生育具有重要意义,因为在这个时代,许多妇女往往因为事业的需要,将尝试怀孕的时间推迟到35岁左右。这种众所周知的与年龄相关的生育力下降的基础是卵巢中静止的卵泡池不断减少。雌性哺乳动物出生时就拥有它们将要拥有的所有卵子。卵巢中的卵子储存在称为卵泡的结构中。在静止(原始)阶段,每个卵泡由卵子(卵母细胞)组成,由一层扁平的称为颗粒细胞的细胞包裹。在生殖过程中,毛囊的涓涓细流离开静止阶段,开始生长。这种情况一直持续到卵子储备耗尽,对于人类女性来说,这会导致更年期,通常是在50岁左右。卵泡从静止期到生长期的过程必须受到严格的调控,以确保正常的生殖寿命。卵母细胞过早耗尽,导致更年期提前,是女性不孕不育的常见原因。人们对控制卵泡开始生长的因素知之甚少。卵巢局部产生的生长因子似乎有重要作用,但有几个可能的候选因素,目前尚不清楚关键因素是什么。在最近发表的一项研究中(这项研究是由之前的BBSRC Grant资助的),我们展示了明确的证据,如果卵巢中的卵泡有一个或多个静止的(原始的)邻居,它们开始生长的可能性要小得多。这强烈地表明原始毛囊产生抑制信号。这一点很重要,因为到目前为止在卵巢中发现的大多数生长因子都会刺激而不是限制卵泡的生长。然而,我们知道某些在卵泡发育中很重要的生长因子(称为骨形态发生蛋白-BMP-因为它们最先在骨骼中被发现)的作用可以被使BMP生长因子失活的蛋白质修饰,从而抑制它们的作用。因此,他们是非常好的候选者,可以成为我们正在寻找的“失踪”的抑制剂(S)。到目前为止,人们对卵巢中这些BMP拮抗剂知之甚少。在我们的初步研究中,我们已经能够证明这些蛋白质中的许多是在卵巢中产生的。在这个项目中,我们将以小鼠卵巢为模型,重点研究这些BMP拮抗剂在卵巢中何时何地产生,以及它们如何受到卵巢内外其他因素的调节。我们在实验室开发了培养整个小鼠卵巢、单个卵泡或从这些卵泡中分离出的细胞的技术,我们将使用这些模型来研究BMP拮抗剂的作用。我们期待这一系列实验的发现将为如何控制卵泡从休眠阶段进入生长期的速度(从而控制生殖寿命)提供新的线索,并为可用于提高家畜,特别是女性的生育能力的治疗提供基础。
英文摘要
Female fertility declines with age and this has important implications for family planning in an era in which many women, often because of the demands of a career, delay attempting to conceive until their mid-late thirties. The basis of this well-described age-related reduction in fertility is the steady loss from the pool of resting follicles in the ovary. Female mammals are born with all the eggs they are ever going to have. The stock of eggs in the ovaries is maintained in structures called follicles. In the quiescent (primordial) stage each follicle consists of the egg (oocyte) enclosed by a single layer of flattened cells called granulosa cells. During reproductive life a steady trickle of follicles leave the quiescent stage and start to grow. This continues until the stock of eggs is exhausted and, in the human female, this results in the menopause, normally at the age of about 50 years. The progression of follicles from the quiescent to the growing phase has to be tightly regulated to ensure a normal reproductive lifespan. Premature depletion of oocytes, leading to an early menopause, is a common cause of infertility in women. Little is known about the factors that control the start of follicle growth. Growth factors produced locally in the ovary seem to have an important role but there are several possible candidates and it is not clear what the key factors are. In a recently published study (that resulted from work funded by a previous BBSRC Grant) we showed clear evidence that follicles in the ovary are much less likely to start growing if they have one or more quiescent (primordial) neighbours. This strongly suggests that primordial follicles produce an inhibitory signal. This is important because most of the growth factors so far identified in the ovary stimulate, rather than restrict, follicle growth. However we know that the action of certain growth factors (known as bone morphogenetic proteins - BMPs - because they were first discovered in bone) which are important in follicle development can be modified by proteins that inactivate BMP growth factors, and therefore inhibit their action. They are therefore very good candidates to be the 'missing' inhibitor(s) that we are looking for. To date little is known about these BMP antagonists in the ovary. In our preliminary studies we have been able to show that many of these proteins are produced in the ovary. In this project, using the mouse ovary as a model, we will focus on where and when these BMP antagonists are produced in the ovary and how they are regulated by other factors within and outside the ovary. We have developed, in our laboratory, techniques for the culture of whole mouse ovaries, individual follicles or cells isolated from these follicles, and we will use these models to study the action of BMP antagonists. We expect the findings from this series of experiments to shed new light on how the rate of entry of follicles from the resting to the growing stages (and hence reproductive lifespan) is controlled and provide the basis for therapies that can be used to improve fertility in both domestic animals and, particularly, in women.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1210/en.2016-1435
发表时间:
2017-01-01
期刊:
Endocrinology
影响因子:
4.8
作者:
[Hardy K, Fenwick M, Mora J, Laird M, Thomson K, Franks S]
通讯作者:
Franks S
The impact of COVID-19 on the provision of Early Years childcare in England and Wales
-
批准号:ES/V013203/1
-
项目类别:Research Grant
-
资助金额:$45.46万
-
财政年份:2020
-
负责人:Kate Hardy
-
依托单位:
Cell shape cell adhesion and regulation of ovarian folliculogenesis
-
批准号:BB/F000014/1
-
项目类别:Research Grant
-
资助金额:$45.37万
-
财政年份:2007
-
负责人:Kate Hardy
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于BMP2/Smad1/Runx2通路调控干细胞成骨分化及桃红四物汤促进骨折愈合的研究
-
批准号:2026JJ80308
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:贺渊哲
-
依托单位:
基于菌群时间节律驱动GLU及BMP2/SMAD1诱导多能干细胞探讨太极拳改善老年慢性疼痛机制研究
-
批准号:2026JJ70009
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张峰
-
依托单位:
桦木酸联合黄芪甲苷调控BMP2-Nrf2-NFκB改善糖尿病合并腰椎间盘突出症的机制研究
-
批准号:JCZRLH202601480
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
针刀介导TGF-β/BMP信号通路调控软骨细胞分化及细胞外基质的合成以维持LDH局部微环境稳态的机制研究
-
批准号:2026JJ82498
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张立勇
-
依托单位:
BMP4 p.H251Y突变抑制巨噬细胞PPARγ-LXRα-ABCA1/G1通路导致青年冠心病的机制研究
-
批准号:JCZRLH202601083
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
THUMPD1通过影响USP4的泛素化调控TGF-β/BMP信号通路对骨形成的作用及机制研究
-
批准号:2026JJ80373
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王湘斌
-
依托单位:
BMP7调控NLRP3 mRNA m6A修饰抑制心肌细胞焦亡改善心梗后心肌损伤和心功能的机制研究
-
批准号:2026JJ81327
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘茂军
-
依托单位:
RUNX1通过BMP2/Smad信号轴调控肿瘤相关巨噬细胞M2极化促进膀胱癌进展的机制研究
-
批准号:2026JJ81626
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黎勇林
-
依托单位:
"BMP2/4--ST6GalNAc1/2"信号轴对猪肠道粘液层唾液酸化的调控作用及机制研究
-
批准号:2026JJ60375
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李浩
-
依托单位:
机械负荷通过BMP2/SOX9通路调控Piezo1信号通道在抑制软骨下骨退变中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李俊杰
-
依托单位: